These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1099445

  • 21. The use of progestational agents for preterm birth: lessons from a mouse model.
    Elovitz MA, Mrinalini C.
    Am J Obstet Gynecol; 2006 Oct; 195(4):1004-10. PubMed ID: 17000233
    [Abstract] [Full Text] [Related]

  • 22. [Can the high percentage of premature twins be reduced? Thoughts based on an analysis of 243 twin births].
    Sachs H, Kühl HO.
    Zentralbl Gynakol; 1977 Oct; 99(9):552-63. PubMed ID: 560771
    [Abstract] [Full Text] [Related]

  • 23. [Premature delivery: epidemiology, etiologic factors, prevention strategies].
    Diallo FB, Diallo MS, Sylla M, Diaw ST, Diallo TS, Diallo Y, Diakite S.
    Dakar Med; 1998 Oct; 43(1):70-3. PubMed ID: 9827160
    [Abstract] [Full Text] [Related]

  • 24. Cervical cerclage in early pregnancy.
    Angel JL, Pietrantoni M, O'Brien WF, Knuppel RA.
    J Perinatol; 1991 Sep; 11(3):258-61. PubMed ID: 1919825
    [Abstract] [Full Text] [Related]

  • 25. Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
    Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.
    Am J Obstet Gynecol; 2008 Oct; 199(4):389.e1-4. PubMed ID: 18928983
    [Abstract] [Full Text] [Related]

  • 26. [Our procedure and our experience with cervix cerclage with special reference to anomalous findings in "cerclage children"].
    Kästner W.
    Geburtshilfe Frauenheilkd; 1971 Nov; 31(11):1065-9. PubMed ID: 5159211
    [No Abstract] [Full Text] [Related]

  • 27. Patients with a prior failed transvaginal cerclage: a comparison of obstetric outcomes with either transabdominal or transvaginal cerclage.
    Davis G, Berghella V, Talucci M, Wapner RJ.
    Am J Obstet Gynecol; 2000 Oct; 183(4):836-9. PubMed ID: 11035322
    [Abstract] [Full Text] [Related]

  • 28. Poor perinatal outcome associated with retained cerclage in patients with premature rupture of membranes.
    Ludmir J, Bader T, Chen L, Lindenbaum C, Wong G.
    Obstet Gynecol; 1994 Nov; 84(5):823-6. PubMed ID: 7936520
    [Abstract] [Full Text] [Related]

  • 29. 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery.
    Facchinetti F, Dante G, Venturini P, Paganelli S, Volpe A.
    Am J Perinatol; 2008 Sep; 25(8):503-6. PubMed ID: 18756431
    [Abstract] [Full Text] [Related]

  • 30. [Perinatal care and mortality in French Guyana. From 1992-1999].
    Cardoso T, Carles G, Patient G, Clayette P, Tescher G, Carme B.
    J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):345-55. PubMed ID: 12843883
    [Abstract] [Full Text] [Related]

  • 31. [Our experiences with Mayer-Ringpessary in the prevention of premature labor (author's transl)].
    Jirátko K, Baran P, Zábranský F.
    Zentralbl Gynakol; 1977 Jun; 99(4):220-8. PubMed ID: 855514
    [Abstract] [Full Text] [Related]

  • 32. Prevention of preterm birth.
    Creasy RK, Herron MA.
    Semin Perinatol; 1981 Jul; 5(3):295-302. PubMed ID: 7025219
    [No Abstract] [Full Text] [Related]

  • 33. Progestogen administration in pregnancy may prevent preterm delivery.
    Keirse MJ.
    Br J Obstet Gynaecol; 1990 Feb; 97(2):149-54. PubMed ID: 2138496
    [Abstract] [Full Text] [Related]

  • 34. [Is tocolytic treatment required for surgical closure of cervix? (author's transl)].
    Matthes U, Junge WD.
    Zentralbl Gynakol; 1981 Feb; 103(13):763-71. PubMed ID: 7197445
    [Abstract] [Full Text] [Related]

  • 35. The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.
    Rebarber A, Cleary-Goldman J, Istwan NB, Rhea DJ, Desch C, Russo-Stieglitz K, Saltzman DH.
    Am J Perinatol; 2008 May; 25(5):271-5. PubMed ID: 18401840
    [Abstract] [Full Text] [Related]

  • 36. Letter: Risks and benefits of hormonal agents in pregnancy.
    Kohrman AF, Jones LA, Bern HA.
    N Engl J Med; 1976 Mar 11; 294(11):614-5. PubMed ID: 942759
    [Abstract] [Full Text] [Related]

  • 37. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
    Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, Heine RP, Nugent RP, Fischer ML, Leveno KJ, Wapner R, Varner M.
    N Engl J Med; 2000 Feb 24; 342(8):534-40. PubMed ID: 10684911
    [Abstract] [Full Text] [Related]

  • 38. A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor.
    Bréart G, Lanfranchi M, Chavigny C, Rumeau-Rouquette C, Sureau C.
    Int J Gynaecol Obstet; 1979 Feb 24; 16(5):381-4. PubMed ID: 86468
    [Abstract] [Full Text] [Related]

  • 39. Clinical characteristics of women prescribed 17 alpha-hydroxyprogesterone caproate in the community setting.
    Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.
    Am J Obstet Gynecol; 2007 Sep 24; 197(3):262.e1-4. PubMed ID: 17826412
    [Abstract] [Full Text] [Related]

  • 40. Cesarean section on request at 39 weeks: impact on shoulder dystocia, fetal trauma, neonatal encephalopathy, and intrauterine fetal demise.
    Hankins GD, Clark SM, Munn MB.
    Semin Perinatol; 2006 Oct 24; 30(5):276-87. PubMed ID: 17011400
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.